Safety and efficacy of bone marrow derived progenitor cells in patients with chronic ischaemic heart failure
Bone marrow stem/progenitor cell (BMSC) therapy for cardiac repair in humans is yet to fulfil the exciting potential demonstrated in preclinical experiments. This thesis presents three clinical studies addressing some of the unresolved issues regarding the ideal delivery method, the effect of patien...
Main Author: | Mozid, Abdul M. |
---|---|
Published: |
Queen Mary, University of London
2012
|
Subjects: | |
Online Access: | https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.664878 |
Similar Items
-
Bone marrow derived cells as endothelial precursors and the role of multi-potent progenitor cells in repairing ischaemic tissues
by: Wragg, Andrew
Published: (2007) -
Bone marrow resident and circulating progenitor cells in patients undergoing cardiac surgery
by: Dotsenko, Olena
Published: (2010) -
Adaptive mechanisms of the heart to ischaemic stress
by: Lockie, Tim
Published: (2012) -
The role of myocardial glycogen in the ischaemic heart
by: Chao, Feng Zhi
Published: (1998) -
Family risks in ischaemic heart disease
by: Slack, J.
Published: (1972)